Annis Gardner Whiting Capital Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,015
Closed -$9.83K 1367
2025
Q2
$9.83K Sell
1,015
-7,935
-89% -$81.8K ﹤0.01% 721
2025
Q1
$133K Sell
8,950
-109
-1% -$1.68K 0.06% 233
2024
Q4
$135K Sell
9,059
-72
-0.8% -$1.17K 0.04% 240
2024
Q3
$175K Buy
9,131
+72
+0.8% +$1.49K 0.05% 223
2024
Q2
$188K Sell
9,059
-20
-0.2% -$397 0.05% 218
2024
Q1
$171K Buy
9,079
+20
+0.2% +$343 0.06% 204
2023
Q4
$131K Buy
9,059
+4,403
+95% +$59.9K 0.06% 191
2023
Q3
$80.8K Buy
+4,656
New +$97.1K 0.04% 237

Other funds holding OGN

Annis Gardner Whiting Capital Advisors's OGN Position: Q3 2025 in Review

Annis Gardner Whiting Capital Advisors sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 1,015 shares — an estimated $9.83K sold.

Annis Gardner Whiting Capital Advisors first reported a position in OGN in Q3 2023 and held it in 8 quarters. The position peaked at $188K in Q2 2024. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Annis Gardner Whiting Capital Advisors reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 1,015 Organon & Co shares in Q3 2025, an estimated $9.83K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Organon & Co in Q3 2023 and held it in 8 quarters.
  • Annis Gardner Whiting Capital Advisors's Organon & Co position peaked at $188K in Q2 2024.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.